Perfil
Deborah Baron is currently Chief Executive Officer at Amplyx Pharmaceuticals, Inc., Director at Seagen, Inc. since 2023, Independent Director at Cerevel Therapeutics Holdings, Inc. since 2021, Director at Cerevel Therapeutics, Inc., Director at Metsera, Inc. starting in 2025, and President at Encysive Pharmaceuticals, Inc. Former roles include Director at Global Blood Therapeutics, Inc., President & Director at Trillium Therapeutics, Inc., and Senior VP-Worldwide Business Development at Pfizer Inc. Education includes undergraduate studies at Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
Cargos activos de Deborah Baron
| Empresas | Cargo | Inicio |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Director/Miembro de la Junta | 20/01/2021 |
| SEAGEN INC. | Director/Miembro de la Junta | 14/12/2023 |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Director Ejecutivo | - |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Director/Miembro de la Junta | - |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Presidente | - |
Antiguos cargos conocidos de Deborah Baron.
| Empresas | Cargo | Fin |
|---|---|---|
| TRILLIUM THERAPEUTICS | Presidente | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Director/Miembro de la Junta | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Formación de Deborah Baron.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Trillium Therapeutics, Inc.
Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
- Bolsa de valores
- Insiders
- Deborah Baron
















